Defense (DTII) Technologies International Corp. Announces Maryland Marketing Campaign
Should it be a surprise that we learned just last week in the company’s 8-K that PetVivo Holdings, Inc. (OTCQB: PETV) adopted and approved an amended and restated “Charter of the Audit Committee”, “Charter of the Compensation Committee” and a “Nominating and Corporate Governance Committee Charter?” All of which are required by NASDAQ.
In the interim, no patients can get the drug via emergency IND because the FDA has stopped that access. This is a point of moral outrage. By not looking at the interim data for leronlimab in an urgent fashion the FDA is condemning thousands of people to death daily.
This Thanksgiving, with so many families unable or unwilling (often smartly), to get together during the holiday, such a historically lazy and obvious answer has been suddenly endowed with real meaning.
There is a niche biotech company called PetVivo, Holdings, Inc. (OTCQB: PETV). They are an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets. PetVivo is benefiting from trials on the human side with a lower barrier to approval for pets.
Yes, even after that Pfizer thing. And neither are any of those cruise or airplane stocks. While the week began as the long-awaited rotation out of stay-at-home tech and into the beaten-down travel sector, the rotation already came and went. It lasted a whole day, long enough to sell those cruise stocks on the pop—I did.
Epazz DeskFlex desk and room booking software is adding a vaccine management solution that tracks employees' COVID-19 vaccination.
Have a look at PetVivo Holdings, Inc. (OTCQB: PETV). The stock has recently moved from a low of about $.20 per share up to over $1.60 on increasing volume.
Epazz, Inc.’s, DeskFlex (OTC: EPAZ), recently announced confirmation that DeskFlex desk booking software is signing up about five new customers per week. This increase in sales will be seen in the third quarter financials.
Health insurer UnitedHealth Group (NYSE: UNH) rose 10%, while Cigna Corp (NYSE: CI) andAnthem Inc (NYSE: ANTM) jumped by double digits. These three stocks are solid buys for broad-sector exposure. But there is no healthcare company more perfectly positioned to benefit for what will be a long, dark winter of germs than Teledoc (NYSE: TDOC).